ACT Capital Management »

Adlai Nortye Ltd Sponsored shares owned by ACT Capital Management

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $311k 27k 11.50

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Abivax Sa Sponsored Ads (ABVX)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Arrowhead Pharmaceuticals (ARWR)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Nektar Therapeutics Com New (NKTR)
Tesla Motors (TSLA)
Cytokinetics (CYTK)
Ast Spacemobile Com Cl A (ASTS)
Palvella Therapeutics Inc Ne (PVLA)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)

View all positions for ACT Capital Management

Top funds holding Adlai Nortye Ltd Sponsored

VR Adviser
Cormorant Asset Management
Squadron Capital Management
Balyasny Asset Management
Millennium Management
Casdin Capital
Adage Capital Partners GP
Superstring Capital Management
Woodline Partners
Affinity Asset Advisors
UBS Group
Ameriprise Financial
ADAR1 Capital Management
T. Rowe Price Associates
Toroso Investments

View all funds holding Adlai Nortye Ltd Sponsored